通过工程外体大分子 (engineered exosomal Macromolecules) 推进阿尔茨海默病治疗
Smita Jain1, Ankita Murmu1, Aparna Chauhan1
1Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India.
Brain research
|March 22, 2025
概括
外体,细胞外囊泡,显示出治疗和诊断阿尔茨海默病 (AD) 的希望. 它们的天然药物输送能力为神经退行性疾病提供了高效,低副作用的治疗选择.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 生物技术和药物输送 生物技术和药物输送
背景情况:
- 外体,作为细胞外囊泡 (EVs),在神经退行性疾病 (NDDs) 的病理生理学中发挥作用,如阿尔茨海默病 (AD).
- 这些囊泡可以运输治疗性和致病性分子,使它们成为研究的焦点.
研究的目的:
- 对阿尔茨海默病中外体的治疗和诊断潜力进行现有文献的审查.
- 探索用于药物输送和早期检测NDDs的外体体背后的逻辑.
主要方法:
- 在NDD中调查外体功能的研究的文献综述.
- 对药物输送应用的外体特征的分析.
- 在疾病诊断和预测中对外体实用性的评估.
主要成果:
- 外体体显示出作为具有免疫性降低的天然药物输送载体的潜力.
- 他们为阿尔茨海默病提供有效的药物治疗,副作用最小.
- 外体正在探索用于早期诊断和预测神经退行性疾病.
结论:
- 外体对阿尔茨海默氏症治疗具有重要的治疗前景.
- 它们作为NDD的诊断和预测工具的作用是正在进行的有希望的研究领域.
相关概念视频
01:22Alzheimer's Disease: Treatment
139
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
139
01:26Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405